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ADULT: AORTIC VALVE

Gradient and pressure recovery of a self-expandable
transcatheter aortic valve depends on ascending aorta size:
In vitro study
Milad Samaee, PhD,a Hoda Hatoum, PhD,a,b,c Michael Biersmith, MD,d Breandan Yeats, MS,a
Shelley C. Gooden, MS,a Vinod H. Thourani, MD,e Rebecca T. Hahn, MD,f Scott Lilly, MD, PhD,d
Ajit Yoganathan, PhD,a and Lakshmi Prasad Dasi, PhDa
ABSTRACT

Bigger ascending aorta

Objective: In this study we aimed to understand the role of interaction of the Medtronic Evolut R transcatheter aortic valve with the ascending aorta (AA) by evaluating the performance of the valve and the pressure recovery in different AA
diameters with the same aortic annulus size.
Methods: A 26-mm Medtronic Evolut R valve was tested using a left heart simulator
in aortic root models of different AA diameter (D): small (D ¼ 23 mm), medium
(D ¼ 28 mm), and large (D ¼ 34 mm) under physiological conditions. Measurements of pressure from upstream to downstream of the valve were performed using a catheter at small intervals to comprehensively assess pressure gradient and
pressure recovery.
Results: In the small AA, the measured peak and mean pressure gradient at vena
contracta were 11.5  0.5 mm Hg and 7.8  0.4 mm Hg, respectively, which
was higher (P < .01) compared with the medium (8.1  0.4 mm Hg and
5.2  0.4 mm Hg) and large AAs (7.4  1.0 mm Hg and 5.4  0.6 mm Hg). The
net pressure gradient was lower for the case with the medium AA (4.1  1.2 mm
Hg) compared with the small AA (4.7  0.8 mm Hg) and large AA (6.1  1.4 mm
Hg; P < .01).
Conclusions: We have shown that small and large AAs can increase net pressure
gradient, because of the direct interaction of the Medtronic Evolut R stent with
the AA (in small AA) and introducing higher level of turbulence (in large AA). AA
size might need to be considered in the selection of an appropriate device for transcatheter aortic valve replacement. (JTCVS Open 2022;9:28-38)

(same Evolut R and annulus size)
PG

Pinwheeling

Flow turbulence

For the same Evolut R (Medtronic) and annulus
size, gradients strongly depend on the ascending
aorta size.

CENTRAL MESSAGE

The size of ascending aorta might
be an important parameter for
the self-expandable transcatheter
heart valve sizing and valve choice.
PERSPECTIVE
For the ﬁrst time, we have examined the inﬂuence
of the varying AA diameters within an acceptable
range on the Medtronic Evolut R TAVR device’s
performance and pressure recovery. We demonstrated that for the same Evolut R and annulus
size, pressure gradients strongly depend on the
AA size.
See Commentaries on pages 39 and 41.

From the aDepartment of Biomedical Engineering, Georgia Institute of Technology,
Atlanta, Ga; bDepartment of Biomedical Engineering, Michigan Technological
University, Houghton, Mich; cHealth Research Institute, Center of Biocomputing
and Digital Health and Institute of Computing and Cybernetics, Michigan Technological University, Houghton, Mich; dDepartment of Surgery, Ohio State University, Columbus, Ohio; eDepartment of Cardiovascular Surgery, Marcus Valve
Center, Piedmont Heart Institute, Atlanta, Ga; and fDivision of Cardiology,
Columbia University Medical Center, New York, NY.
This work was partially supported by the National Institutes of Health under award
numbers R01HL119824 and R21HL139208.

28

JTCVS Open c March 2022

Received for publication Jan 25, 2021; accepted for publication Jan 12, 2022;
available ahead of print Feb 17, 2022.
Address for reprints: Lakshmi Prasad Dasi, PhD, Wallace H. Coulter Department of
Biomedical Engineering, Georgia Institute of Technology and Emory University,
Technology Enterprise Park (TEP), 387 Technology Circle, Office 232, Atlanta,
GA 30313-2412 (E-mail: lakshmi.dasi@gatech.edu).
2666-2736
Copyright Ó 2022 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
https://doi.org/10.1016/j.xjon.2022.01.003

Samaee et al

Abbreviations and Acronyms
AA ¼ ascending aorta
AS
¼ aortic stenosis
BE
¼ balloon-expandable
Echo ¼ Doppler echocardiography
LV
¼ left ventricle
LVOT ¼ left ventricular outflow tract
PG
¼ pressure gradient
PI
¼ pinwheeling index
PR
¼ pressure recovery
SE
¼ self-expandable
T
¼ instantaneous time during cardiac cycle
TAVR ¼ transcatheter aortic valve replacement
THV ¼ transcatheter heart valve
VC ¼ vena contracta

Video clip is available online.

Transcatheter aortic valve replacement (TAVR) has emerged
as a minimally invasive alternative to the highly invasive surgical aortic valve replacement for severe, symptomatic aortic
stenosis (AS); however, surgical aortic valve replacement is
still the gold standard. For patients who are candidates for
bioprosthetic valve replacement, recent societal guidelines
give a class I indication to consideration for TAVR, depending on a balance of life expectancy and valve durability.1
Recent studies suggest mortality rates might differ for the 2
commercially available transcatheter heart valves (THVs),
favoring the balloon-expandable (BE) valve2,3 despite reports
suggesting higher post-TAVR gradients compared with the
self-expandable (SE) valve.4 The 2 key hemodynamic parameters for evaluation of aortic valve performance are
mean and peak transvalvular pressure gradients (PGs).1,5-7
Peak gradient occurs at the vena contracta (VC); beyond
the point of the VC (within the ascending aorta [AA]), the
blood flow decelerates and kinetic energy (velocity) is
consequently converted back to potential energy (pressure).
This phenomenon is called pressure recovery (PR) and
might significantly affect the calculation of aortic valve
effective orifice area8,9; however, PR is not typically quantified using standard noninvasive measurements.
A standard noninvasive approach to assessing transvalvular PG after prosthetic aortic valve replacement is
Doppler echocardiography (Echo)10,11 to measure the
transvalvular peak velocity at the VC and then calculating
peak PG using the simplified Bernoulli equation. There is
also an invasive approach to evaluate PG using percutaneous cardiac catheterization.12 This technique usually
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requires the use of a side-hole catheter within the AA,
thus measuring pressures beyond the VC. PGs on the basis
of Echo and catheter represent valuable information about
valve performance but have frequently been reported to be
discordant with Echo, with overestimation of invasive
measurements, and with other imaging modalities.6,13 A
significant clinical knowledge gap exists in measurements
for these 2 distinct modalities.
The process of selecting the appropriate THV relies
on computed tomography measurements of the annulus
size.14,15 In a recent study from our group,16 an in vitro
PR comparison was performed for a BE and SE THV.
This study highlighted the influence of the taller SE stent
frame on the efficiency of PR16,17 through interaction
with the downstream flow in the AA and causing disturbances in the flow field. The fluttering of the THV leaflets
also helped in increasing the level of turbulence. In that
study, it was also shown that the SE THV has a lower PR
and lower PG at the VC (PGmax) compared with the BE
THV.16 The lower PR with the SE THV compared with
the BE THV was not observed in a study by Stanova and
colleagues.18 In their study, the 2 THV types had similar
PR (approximately 45%). They also reported that the SE
THV had a lower mean gradient compared with the BE
THV and argued that it is because the stent was not compressed by the aortic walls. However, other studies have
shown that pre-valve, in-stent increases in gradient (thus
not related to valve function) are seen with the BE THV
and might account for these measured differences.16,19 As
a result, it is important to assess the hemodynamics of the
SE THV when it interacts with different AA sizes. The
objective of this study was to examine the influence of the
AA size on the performance of an implanted SE transcatheter aortic valve. To achieve this goal, 3 sets of aortic chambers with the same geometrical features except AA size
were used.
METHODS
Left Heart Simulator
An in vitro experimental setup was developed to investigate the role of
the AA size on the performance of a 26-mm Evolut R (Medtronic) valve. A
left heart simulator was used to subject pulsatile flow on a 26-mm Evolut R
THV at 3 different AA sizes. Although sinus size is also a function of the
aortic annulus, this parameter was set constant for the 3 different AA sizes.
The selected AA sizes were derived from the patient statistical distribution
and span the distribution of the normal value of AA sizes.14 The size and
label of the aortic chambers used are tabulated in Table 1. The small, medium, and large AAs were selected on the basis of the 5th, 50th, and 95th
percentile of the distribution, respectively.
The flow loop consists of a reservoir, a bioprosthetic mitral valve, a
bladder pump (acting as the left ventricle [LV]) controlled by a custom
LabVIEW program and driven by compressed air, an aortic chamber model
in which a 26-mm Medtronic Evolut R valve was placed, and a compliance
chamber and resistance valve to control the aortic pulse pressure. The schematic of this pulse duplicator left heart simulator is shown and described in
previous studies.20,21 The loop was filled with a water-glycerin mixture
(40% glycerin by volume) to mimic the blood properties (kinematic

JTCVS Open c Volume 9, Number C

29

Adult: Aortic Valve

Samaee et al

TABLE 1. Dimensions of all 3 aortic chambers with different AA sizes
Label

Small AA

AA diameter (mm)
AA/annulus ratio

Medium AA

Large AA

23

28

34

1.05

1.27

1.55

In all 3 chambers, the size of the aortic annulus is D0 ¼ 22 mm. AA, Ascending aorta;
D0, aortic annulus size.

viscosity ¼ 3.3 mm2/s; density ¼ 1080 kg/m3) at room temperature (25 C).
The aortic chamber model is as shown in Figure 1. The aortic valve annulus
is located at X ¼ 0 cm, and the Evolut was deployed as recommended in the
report by Giannini and colleagues.22

Experimental Protocols
The flow loop imposed physiological hemodynamics (peak aortic
flow ¼ 24.2  0.2 L/min; heart rate ¼ 60 beats per minute; systolic/diastolic aortic pressure ¼ 120/80  1 mm Hg) in all 3 sets of experiments.

The aortic annulus size (D0) was kept constant (D0 ¼ 22 mm, the appropriate annular dimensions for a 26-mm Evolut R THV23,24) in all experiments, and the only variable parameter was the size of the AA as shown
in Figure 1. The inflow diameter of the 26-mm Evolut R valve is 26 mm,
with a frame height of 45 mm, skirt height of 13 mm, and stent top diameter
of 32 mm.25 Thus, the distal (aortic) edge of the fully-opened leaflet is
located at X ¼ 2.4 cm as shown in Figure 1.

Data Acquisitions
Flow data were acquired using a clamp-on ultrasonic flowmeter
(Transonic Systems Inc). Pressure measurements were performed along
the axial center line of the aortic root from upstream to downstream of
the valve using a Millar catheter (ADInstruments Inc) with intervals of
1 mm inside the valve and 5 mm downstream of the valve. Pressure
measurement was performed on a total length of 10 cm (Figure 1).
X ¼ 0 cm corresponds to the first measurement location, which is the
ventricular pressure (upstream of the valve annulus). X ¼ 10 cm

A

D1

B

D2

C

D3

0

1

2

3

4
5
6
Axial Location, X [cm]

7

8

9

10

FIGURE 1. The experimental setup of a deployed Evolut R (Medtronic) transcatheter aortic valve in aortic root chambers of the left heart simulator. X ¼ 0
denotes the annulus. The Evolut R valve is deployed in chambers with different ascending aorta (AA) size: (A) small AA (D1 ¼ 23 mm), (B) medium AA
(D2 ¼ 28 mm), and (C) large AA (D3 ¼ 34 mm). The diameter of the aortic annulus is D0 ¼ 22 mm in (A), (B), and (C). D0, aortic annulus size; D1, small AA
size; D2, medium AA size; D3, large AA size.
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corresponds to the last measurement location, which is the furthermost
downstream location (Figure 1). Physiological hemodynamics imposed
include physiological LV pressures observed at 0 cm upstream of the
aortic valve annulus and physiological aorta pressures observed
5.5 cm downstream of the aortic valve annulus. Data were acquired
for 200 consecutive cardiac cycles at a sampling rate of 100 Hz for
each axial location.
En-face images were recorded using a high-speed camera at a frame rate
of 1 kHz. Using the en-face image in diastole, pinwheeling index (PI) was
calculated, similar to previous publications,20,26,27 as follows:
Lactual Lideal
3100
PI ¼
Lideal
Where Lactual and Lideal represent the deflected and unconstrained free edge
of the leaflet, respectively. The PI indicates leaflet durability28,29 and quantifies the amount of leaflet twisting. Pinwheeling is correlated with premature tissue degradation26 and should be minimized in the leaflet
postdeployment.

Data Postprocessing
The mean pressure and SD were calculated at a given time and axial
location across the 200 cycles. The PG was defined as the difference between the upstream pressure at the first location of X ¼ 0 (ventricular pressure) and the pressure value at each location. We report on 2 PGs: peak flow
PG and mean PG. Peak flow PG is considered as the PG at the peak flow
time point (note this differs from peak PG, which occurs earlier than the
peak flow time16). Mean PG is the mean value of PG at each location, calculated by averaging the positive values of PG during the forward flow at
the given location. PGmax, PG at recovery zone (PGnet), and PR
(PR ¼ PGmaxPGnet) were calculated (Figure 2). The PR zone was defined
as the measured pressure at the end of the aortic root chamber (the typical
pullback range is 5-8 cm from the aortic annulus as shown in Figure 3). We

calculated PGnet on the basis of the PG at X ¼ 7 cm. PR percentages were
calculated as follows:
PGmax PGnet
PR percentage ¼ 1003
PGmax

Statistical Analysis
The pressure data were analyzed using JMP Pro 15 (SAS Institute) to
evaluate PGs at the VC and recovery zone within the 3 sizes of aortic
chambers. The non-normality of the data was confirmed using the
Kolmogorov–Smirnov test with P < .15. The Wilcoxon method was
used for nonparametric comparison of PGs at the VC and recovery zone
pairwise for the AA sizes.

Patient Data Collection
One hundred fifty-six patients who underwent TAVR with a selfexpanding CoreValve prosthesis (Medtronic Inc) between January 2015
and November 2019 at Ohio State University Wexner Medical Center
were retrospectively analyzed with institutional review board approval
(protocol title: OSU: Developing Precision Medicine Guidelines for
Trans-Catheter Aortic Valve Replacement; principal investigator: Lakshmi
Prasad Dasi; protocol number: H20010; Approval date: February 27,
2020). After deployment, the invasive PGs were measured via catheterization. Transducers were zeroed immediately before measurement, and the
pressure was measured 3 cm above the annulus and averaged over 5 cardiac
cycles. Echo was performed within 24 hours of the procedure, and Doppler
PGs were measured across the valve. The PR was then calculated in each
patient as the difference between the Echo PG and the catheter-derived
gradient. This is because the catheter-derived gradient is measured between
the valve and AA, thus factoring the PR.

D

y

D0

x

LVOT

Recovery zone
Recovery zone
Typical pullback
range (5 to 8 cm
from the annulus)

Pressure Gradient

LVOT

PGnet

PGmax
PR

Acceleration

VC

Deceleration

Axial Distance
FIGURE 2. Peak and net gradients. Upstream and downstream of the valve represent left ventricular outflow tract (LVOT) and the recovery zone, respectively. By crossing blood flow through the aortic valve, pressure does not recover to the LVOT pressure values, because of energy losses. The amount of
pressure recovered at the recovery zone (difference between peak pressure and net pressure) is called pressure recovery (PR). The typical pullback range
is 5 to 8 cm from the annulus. Do, aortic annulus size; D, diameter; PGmax, PG at VC; PGnet, PG at recovery zone; VC, vena contracta.
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FIGURE 3. Averaged and standard deviation of the measured pressures as a function of axial length. Each curve is an average of 200 consecutive cardiac
cycles. Averaged pressures at 8 different time points during systole from aortic flow acceleration to deceleration are plotted at (A) small ascending aorta
(AA), (B) medium AA, and (C) large AA. The horizontal axis represents the longitudinal direction along the aortic chamber center line. Pressure standard
deviation at 8 different time points during systole from aortic flow acceleration to deceleration are plotted at (D) small AA, (E) medium AA, and (F) large
AA. The maximum flow rate occurs at T ¼ 0.26 seconds (magenta line). The green shaded area represents the region of the valve from the inflow entrance to
the edge of the fully-opened leaflet (dashed line).
The diameter of the AA was measured from Echo, and the size of the
THV was recorded for each patient. The ratio of the AA diameter to the
THV size was calculated and used to split the patient population into 2
groups. The large AA group was classified as being above the average
AA diameter to THV size ratio and the small AA group was classified as
being below this average ratio. The PR was then compared between the
2 groups.

RESULTS
The opening and closing of the valve leaflets for different
AA sizes are shown in Video 1. These videos are recorded

VIDEO 1. En-face imaging views of the Evolut R (Medtronic) at 3
different aortic chamber arrangements throughout systole. Video available
at: https://www.jtcvs.org/article/S2666-2736(22)00009-2/fulltext.
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during systole plus 100 ms after valve closure for visualizing and measuring the PI. The highest PI value was
observed in the small AA case (17.1%  2.9%), followed
by medium AA (8.9%  1.5%) and large AA (3.3%
 0.6%). Cycle-averaged pressure and pressure SD curves
are plotted as a function of axial distance in Figure 3. The
green shaded region shows the valve region, and the dashed
line represents the fully opened leaflet at X ¼ 2.6 cm. As a
general trend in Figure 3, pressure values start dropping in
the left ventricular outflow tract (LVOT) region from X ¼ 0
to the lowest value at the VC. Peak flow occurs at T ¼ 0.26 s
(flow curves are presented in Figure 4, A).
SD pressures are plotted versus axial distance during
systole at different time points in Figure 4, D-F. The
magnitude of SD downstream from the stent frame is
higher than the valve region and LVOT. Also, higher fluctuations in pressure were observed with larger AAs, with a
maximum value of fluctuation in the large and medium
AAs of 2.1 mm Hg.
Flow rate curves are plotted in Figure 4, A. The peak flow
rate is shown by a vertical black dashed line in Figure 4, A,
and horizontal dashed lines in Figure 4, B-G. The values of
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FIGURE 4. Measured aortic flow rates and calculated pressure gradients (PG) and corresponding standard deviations (SD) at different ascending aorta (AA)
sizes. A, Averaged 200 consecutive cardiac cycles of aortic flow rate in different sizes of AA. Error bars represent standard deviations. Pressure gradient
contours at continuous time points (T) from the start of systole (T ¼ 0 seconds) to approximately the end of systole (T ¼ 0.36 seconds) at different AA sizes:
(B) small AA, (C) medium AA, and (D) large AA. The horizontal axis in (B-G) represents the longitudinal direction along the aortic chamber center line.
Pressure gradient standard deviation contours at continuous time points from the start of systole (T ¼ 0 seconds) to the end of systole (T ¼ 0.36 seconds) at
different AA sizes: (E) small AA, (F) medium AA, and (G) large AA. The vertical dashed line in (A) and also the horizontal line in (B-G) shows the peak
flow rate (T ¼ 0.26 seconds). The vertical dashed lines in (B-G) represent the region of the valve from the inflow entrance to the edge of the fully-opened
leaflet and the rightmost one shows the end of the stent frame.
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FIGURE 5. Pressure gradient (PG) curves as a function of axial distance at different ascending aorta (AA) size. A, Peak PG and (B) Mean PG. Shaded
curves indicate standard deviations. The horizontal axis represents the longitudinal direction along the aortic chamber center line. The green shaded
area represents the region of the valve from the inflow entrance to the edge of the fully-opened leaflet (dashed line). The orange shaded region shows
the typical pullback traces of the pressure catheter perform by surgeons. The vertical dashed black line shows X ¼ 7 cm, where we calculated PG at recovery
zone (PGnet).
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X ¼ 4.5 cm) depicts the end of the stent frame (Figure 4, BG). As visible in the SD contours in Figure 4, E-G, flows
distal to the stent frame (at X ¼ 4.5 cm) are more fluctuated.
Peak flow PG and mean PG curves for all 3 AA sizes are
presented in Figure 5, A and Figure 5, B, respectively. The
small AA has the highest PGmax (11.5  0.5 mm Hg;
P <.01) compared with the medium AA (8.1  0.4 mm
Hg) and large AA (7.4  1.0 mm Hg). The net PG is lower
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PG and corresponding pressure SD contours for all 3 cases
are plotted as a function of systolic time and axial distance
in Figure 5. As clearly visible in Figure 4, B-D, the peak PG
occurs during the flow acceleration (T ¼ approximately
0.2 s), which is approximately 60 ms before the peak flow
rate (at T ¼ 0.26 s) in the cardiac cycle. The valve leaflet
range is depicted between X ¼ 0 and the first vertical dashed
line (at X ¼ 2.5 cm). The rightmost vertical dashed line (at
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FIGURE 6. Pressure gradient (PG) and pressure recovery at 3 different ascending aorta (AA) sizes. Each data point is an average of 200 consecutive cardiac
cycles. Pressure gradient at peak flow and mean pressure gradient are summarized as a function of the diameter of AA to the diameter of the annulus ratio at
(A) vena contracta and (B) recovery zone. C, Pressure recovery percentage, which is defined as the difference between peak gradient and net gradient divided
by peak gradient. Error bars denote standard deviations. PGmax, PG at VC; DAA, AA diameter; DAnnulus, aortic annulus diameter; PGnet, PG at recovery zone.
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with medium AA (4.1  1.2 mm Hg; P <.01) compared
with the small AA (4.7  0.8 mm Hg) and large AA
(6.1  1.4 mm Hg).
The values of PGmax and PGnet at X ¼ 7 cm are summarized in Figure 6 as a function of the ratio of the AA size
to the annulus size. Also, PR percentages are plotted in
Figure 6, C. PR percentage in peak flow PG is
59.2%  5.3%, 48.4%  9.6%, and 16.6%  16.8% in
the small, medium, and large AA sizes, respectively. PR percentage in mean PG is 28.5%  5.2%, 22.3%  8.5%, and
12.8%  10.3% in the small, medium, and large AA sizes,
respectively, as shown in Figure 6, C. Among the 3 AA sizes,
differences in PG at peak flow and at mean PG measured at
the VC and at the recovery zone were seen.
PR values in human studies were defined as the difference between Echo and catheter PGs and are plotted in
Figure 7. The dataset was classified to 2 groups of AA sizes
as large and small AA.
DISCUSSION
Patient-specific studies highlighted conflicting results
when it comes to estimating PR in AS and TAVR patient cohorts.30-32 Studies in native AS patients have suggested that
PR can be estimated on the basis of the severity of AS and

PGDoppler – PGCatheter [mm Hg]

20
15
10
5
0
–5
–10
–15

P - value: .037
Small AA

Large AA

FIGURE 7. Pressure recovery comparison between small and large geometries. Pressure recovery plotted as the echocardiography pressure gradient
subtracted by the catheter pressure gradient on the y-axis versus small and
large geometries on the x-axis defined by the ratio of the ascending aorta
(AA) diameter to the CoreValve (Medtronic) size with small being below
the average and large being above the average. The upper and lower borders of the box represent the upper and lower quartiles. The middle horizontal line represents the median. The upper and lower whiskers
represent the maximum and minimum values of nonoutliers. Extra dots
outside the whiskers represent outliers. PGDoppler, echocardiography pressure gradient; PGCatheter, catheter pressure gradient.

the size of the AA.8 Recent studies showed that using the PR
correction in a cohort of 697 patients resulted in the reclassification of nearly 25% of patients from severe AS to moderate AS. The reclassified moderate AS patients had a
significantly better 4-year clinical event-free survival
compared with patients who remained in the severe AS subgroup.33 However, there is a paucity of data in the TAVR
population. The SE THV is relatively less performed in patients with a dilated AA (>43 mm) or severely angulated
aorta (aortoventricular angle >70 ).34,35 In this study, to
our knowledge for the first time, we have examined the influence of AA diameter (within an acceptable range for the
SE THV) on the performance and PR of the Medtronic Evolut R TAVR device. The Evolut R is characterized by a long,
nitinol stent frame that gets compressed or expanded depending on the surrounding anatomy, in particular the diameter of the AA. Hence, it is important to quantify the effect
of varying AA diameters on the valve’s performance not
only at the leaflet level but also in terms of the net gradient
after taking into account PR effects.
The peak PG is the pressure at the VC subtracted from the
LV pressure. Clinicians measure the peak velocity using
Echo and use the simplified Bernoulli equation to calculate
peak PG. Although the inappropriate assumptions of the
simplified Bernoulli equation might explain some of the differences between Echo and invasive PG measurements,13
other reasons for discordance have long been sought. In
this study, we observed that the peak PG of an Evolut R valve
is dependent on the AA diameter. PGmax decreases with
increasing AA size. Because the stent structure of the Evolut
R valve might be constrained in a small AA, leaflet excursion
might be restricted, resulting in a higher pressure decrease at
the VC. Despite the upper stent frame diameter of 32 mm,
within the 28 and 34 mm AA, the stent structure shape looks
nonconstrained, which results in a comparable jet velocity in
these 2 cases and a corresponding close PGmax.
The net transvalvular PG is the pressure after the recovery has occurred subtracted from the LV pressure. The net
gradient is a key parameter to assess the invasively derived
valve effective orifice area.1,8 We observed the net gradient
is also dependent on the AA size. By crossing blood flow
through the aortic valve, pressure does not recover to the
LVOT pressure values due to energy losses. Hatoum and
colleagues16 showed that pressure fluctuations exist downstream of the SE THV stent, which results in energy losses
and less PR. There is less turbulence distal to the stent frame
in the small AA case compared with the medium and large
AA cases. However, the turbulence in the large AA was high
and leads to a higher net PG. Our results are in agreement
with previous studies, in which they reported low PR and
high energy loss in a dilated aorta.8,36
In this work, PR values at peak flow rate showed a significant difference between the small and large AA (4.9 mm
Hg), which indicates the dependence of PR on AA size.
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Effect of ascending aorta size on the performance of the Evolut R valve

Method:
• 26 mm Evolut R in three different AA sizes
• Catheter-based pressure measurements across the valve
D1 = 23 mm

D2 = 28 mm

D3 = 32 mm

PG [mm Hg]

12
10
8
6
4

D1

D2

D3

Ascending Aorta Diameter

Large AA

Small AA

Evolut R
(26 mm)

Medium AA

X = 7 cm

at VC

at X = 7 cm

Each data point is an average of 200 consecutive
cardiac cycles.

VC

X = 0 cm
22 mm

22 mm

22 mm

Increasing ascending aorta diameter

Increasing ascending aorta diameter

Higher pressure fluctuation downstream of the valve

Less Pinwheeling

FIGURE 8. For the first time, the influence of the varying ascending aorta (AA) diameters within an acceptable range on an self-expandable transcatheter
aortic valve (TAV) device’s performance and pressure recovery have been examined. We studied gradients of the Evolut R (Medtronic) transcatheter aortic
valve replacement (TAVR) device at 3 different AA sizes. We showed that for the same Evolut R and annulus size, peak and mean gradients strongly depend
on the AA size. As a result, the size of AA might be an important parameter for the self-expandable transcatheter heart valve sizing and valve choice. D1,
small AA size; D2, medium AA size; D3, large AA size; PG, pressure gradient; VC, vena contracta.

The small AA showed the highest value of PR
(59.2%  5.3%) compared with the larger AA sizes
(16.6%  16.8%). This could be because of more significant
ambient mixing that occurs with the larger diameter AA
compared with the smaller one. Although the small AA
shows the highest value of PR compared with the large and
medium AAs, the performance of the valve was not the
best in the small AA because the small AA shows the highest
value of maximum PG compared with the other 2 AA diameters. In contrast, the medium AA shows a moderate PR and a
low value of PGmax, which has the best valve performance
among the 3 cases.
Recent studies by Tasca and colleagues37 and Hatoum
and colleagues16 showed that different designs of bioprosthesis aortic valves can alter the position of the VC.
Therefore, the interaction between the valve, the surrounding anatomy, and the flow play a tremendous role in
dictating the spatial variation of pressure. Our study showed
that by increasing the AA size, the position of the VC was
slightly changed toward the AA downstream.

Limitation
The aortic chamber used in this experiment was rigid and
straight, which is not anatomical. However, the main goal of
this study was to compare PGs at 3 different AA sizes, and
36
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because the experimental conditions were not changed
among 3 different conditions, we can rely on the results
of this study. Future work involves performing similar experiments in patient-specific models with compliant material and a geometry that involves the intricate features
in vivo. Another limitation in this study is the use of the
Evolut R transcatheter aortic valve at room temperature.
CONCLUSIONS
The major finding of this study was that interactions between the Evolut R stent frame and AA affect the performance
of the valve and downstream hemodynamics. As summarized
in Figure 8, we showed that the 26-mm Evolut R THV will be
constrained in a small AA, resulting in high peak and mean PG
as well as net PG, despite high PR. Whereas the medium and
large AA chambers allowed for a nonconstrained THV frame
with similar PR, the medium AA chamber (AA to annulus
diameter ratio ¼ 1.32) minimized the ambient peripheral mixing by downstream turbulence compared with the large AA
chamber. Thus, AA size might be an important parameter
for SE THV sizing and valve choice.
Conflict of Interest Statement
Dr Dasi has reported patents on novel polymeric heart
valves, 3D computational predictive modeling for TAVR,

Samaee et al

vortex generators on heart valves, and superhydrophobic/
omniphobic surfaces. Dr Hahn reports speaker fees from Edwards Lifesciences and Philips Healthcare; consulting fees
for Abbott Structural, Boston Scientific, Edwards Lifesciences, Gore & Associates, Medtronic, and Navigate; nonfinancial support from 3mensio; equity with Navigate; and is
Chief Scientific Officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored trials, for which she receives no
direct industry compensation. Dr Thourani is a consultant
for Abbott Vascular, Boston Scientific, Cryolife, Edwards
Lifesciences, Gore Vascular, Jenavalve, and Shockwave.
The remaining authors reported no conflicts of interest.
The Journal policy requires editors and reviewers to
disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict
of interest. The editors and reviewers of this article have
no conflicts of interest.

Adult: Aortic Valve

12.
13.

14.

15.

16.

17.

References
1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al.
2020 ACC/AHA guideline for the management of patients with valvular heart
disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021;
77:e25-197.
2. Deharo P, Bisson A, Herbert J, Lacour T, Etienne CS, Grammatico-Guillon L,
et al. Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable
transcatheter aortic valve implantation in patients with aortic stenosis: data
from a nationwide analysis. Circulation. 2020;141:260-8.
3. Van Belle E, Vincent F, Labreuche J, Auffret V, Debry N, Lefevre T, et al.
Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a propensity-matched comparison from the FRANCE-TAVI Registry. Circulation. 2020;141:243-59.
4. Hahn RT, Leipsic J, Douglas PS, Jaber WA, Weissman NJ, Pibarot P, et al.
Comprehensive echocardiographic assessment of normal transcatheter valve
function. JACC Cardiovasc Imaging. 2019;12:25-34.
5. Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S,
et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr.
2017;30:372-92.
6. Archer GT, Elhawaz A, Barker N, Fidock B, Rothman A, van der Geest RJ, et al.
Validation of four-dimensional flow cardiovascular magnetic resonance for aortic
stenosis assessment. Sci Rep. 2020;10:10569.
7. Bach DS. Echo/Doppler evaluation of hemodynamics after aortic valve replacement: principles of interrogation and evaluation of high gradients. JACC Cardiovasc Imaging. 2010;3:296-304.
8. Garcia D, Dumesnil JG, Durand LG, Kadem L, Pibarot P. Discrepancies
between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard
to quantification of aortic stenosis severity. J Am Coll Cardiol. 2003;41:435-42.
9. Spevack DM, Almuti K, Ostfeld R, Bello R, Gordon GM. Routine adjustment of
Doppler echocardiographically derived aortic valve area using a previously
derived equation to account for the effect of pressure recovery. J Am Soc Echocardiogr. 2008;21:34-7.
10. Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R, et al.
Recommendations for the imaging assessment of prosthetic heart valves: a report
from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J
Cardiovasc Imaging. 2016;17:589-90.
11. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA,
et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiog-

18.

19.

20.
21.
22.

23.
24.

25.

26.

27.

28.

29.

30.

31.
32.

raphy’s Guidelines and Standards Committee and the task force on prosthetic
valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American
Heart Association, the European Association of Echocardiography, a registered
branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the
American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European
Society of Cardiology, the Japanese Society of Echocardiography, and Canadian
Society of Echocardiography. J Am Soc Echocardiogr. 2009;22:975-1014. quiz:
1082-4.
Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012;125:2138-50.
Donati F, Myerson S, Bissell MM, Smith NP, Neubauer S, Monaghan MJ, et al.
Beyond Bernoulli: improving the accuracy and precision of noninvasive estimation of peak pressure drops. Circ Cardiovasc Imaging. 2017;10:e005207.
Freeman LA, Young PM, Foley TA, Williamson EE, Bruce CJ, Greason KL, et al.
CT and MRI assessment of the aortic root and ascending aorta. AJR Am J Roentgenol. 2013;200:W581-92.
Leipsic J, Gurvitch R, LaBounty TM, Min JK, Wood D, Johnson M, et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC
Cardiovasc Imaging. 2011;4:416-29.
Hatoum H, Hahn RT, Lilly S, Dasi LP. Differences in pressure recovery between
balloon expandable and self-expandable transcatheter aortic valves. Ann Biomed
Eng. 2020;48:860-7.
Hatoum H, Yousefi A, Lilly S, Maureira P, Crestanello J, Dasi LP. An in vitro
evaluation of turbulence after transcatheter aortic valve implantation. J Thorac
Cardiovasc Surg. 2018;156:1837-48.
Stanova V, Rieu R, Zenses AS, Rodes-Cabau J, Pibarot P. Doppler versus catheter
transvalvular pressure gradients in self-expanding versus balloon expandable
transcatheter aortic valves, an in vitro study. J Am Coll Cardiol. 2020;75:1443.
Shames S, Koczo A, Hahn R, Jin Z, Picard MH, Gillam LD. Flow characteristics
of the SAPIEN aortic valve: the importance of recognizing in-stent flow acceleration for the echocardiographic assessment of valve function. J Am Soc Echocardiogr. 2012;25:603-9.
Hatoum H, Dasi LP. Spatiotemporal complexity of the aortic sinus vortex as a
function of leaflet calcification. Ann Biomed Eng. 2019;47:1116-28.
Hatoum H, Moore BL, Dasi LP. On the significance of systolic flow waveform on
aortic valve energy loss. Ann Biomed Eng. 2018;46:2102-11.
Giannini C, De Carlo M, Tamburino C, Ettori F, Latib AM, Bedogni F, et al.
Transcathether aortic valve implantation with the new repositionable selfexpandable Evolut R versus CoreValve system: a case-matched comparison.
Int J Cardiol. 2017;243:126-31.
Sinning JM, Werner N, Nickenig G, Grube E. Medtronic CoreValve Evolut R
with EnVeo R. EuroIntervention. 2013;9(Suppl):S95-6.
D’Ancona G, Dißmann M, Heinze H, Zohlnh€ofer-Momm D, Ince H, Kische S.
Transcatheter aortic valve replacement with the 34 mm Medtronic Evolut valve:
early results of single institution experience. Neth Heart J. 2018;26:401-8.
Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am
Coll Cardiol. 2018;71:1360-78.
Hatoum H, Dollery J, Lilly SM, Crestanello J, Dasi LP. Impact of patient-specific
morphologies on sinus flow stasis in transcatheter aortic valve replacement: an in
vitro study. J Thorac Cardiovasc Surg. 2019;157:540-9.
Midha PA, Raghav V, Condado JF, Okafor IU, Lerakis S, Thourani VH,
et al. Valve type, size, and deployment location affect hemodynamics in
an in vitro valve-in-valve model. JACC Cardiovasc Interv. 2016;9:1618-28.
Martin C, Sun W. Simulation of long-term fatigue damage in bioprosthetic heart
valves: effects of leaflet and stent elastic properties. Biomech Model Mechanobiol. 2014;13:759-70.
Doose C, K€utting M, Egron S, Farhadi Ghalati P, Schmitz C, Utzenrath M, et al.
Valve-in-valve outcome: design impact of a pre-existing bioprosthesis on the hydrodynamics of an Edwards Sapien XT valve. Eur J Cardiothorac Surg. 2017;51:562-70.
Mando R, Abbas AE, Gallagher M, Safian RD, Hanzel GS, Pibarot P, et al. Echo
overestimates trans-aortic gradients immediately post tavr: a pressure recovery phenomenon in a simultaneous cath and echo study. J Am Coll Cardiol. 2019;73:1251.
Abbas AE, Pibarot P. Hemodynamic characterization of aortic stenosis states.
Catheter Cardiovasc Interv. 2019;93:1002-23.
Alston M, Orsinelli D, Rushing G, Dasi LD, O’neil S, Matre N, et al. Invasive
versus Doppler-derived gradients after TAVR. JACC Cardiovasc Interv. 2019;
12:S48-9.

JTCVS Open c Volume 9, Number C

37

Adult: Aortic Valve

33. Heo R, Jin X, Oh JK, Kim YJ, Park SJ, Park SW, et al. Clinical usefulness of pressure recovery adjustment in patients with predominantly severe aortic stenosis:
Asian Valve Registry data. J Am Soc Echocardiogr. 2020;33:332-41.e2.
34. Abramowitz Y, Maeno Y, Chakravarty T, Kazuno Y, Takahashi N, Kawamori H,
et al. Aortic angulation attenuates procedural success following self-expandable
but not balloon-expandable TAVR. JACC Cardiovasc Imaging. 2016;9:964-72.
35. Francone M, Budde RPJ, Bremerich J, Dacher JN, Loewe C, Wolf F, et al. CT and
MR imaging prior to transcatheter aortic valve implantation: standardisation of
scanning protocols, measurements and reporting—a consensus document by
the European Society of Cardiovascular Radiology (ESCR). Eur Radiol. 2020;
30:2627-50.

38

JTCVS Open c March 2022

Samaee et al

36. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve
stenosis severity: a new index based on the energy loss concept. Circulation.
2000;101:765-71.
37. Tasca G, Lucherini F, Romagnoni C, Jaworek M, Redaelli A,
Antona C, et al. Effect of the valve design on pressure drop, pressure
recovery, and spatial positioning of vena contracta. Int J Artif Organs.
2020;43:468-75.

Key Words: transcatheter aortic valve, ascending aorta,
pressure recovery, pressure gradient, left heart simulator

